Delivery Order SPE2DB24D1205-SPE2DB25FDAMK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,078.41 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Multaq 400 mg tablets (60-count packages). This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,170.01 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) valued at $1,725.96. This firm fixed price delivery order, issued on August 14, 2025, with completion targeted for August 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through open competition with no set-aside designation, and performance will be fulfilled from the...
- The Defense Logistics Agency awarded a delivery order valued at $9,328.37 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract type. The award, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-set-aside competitive procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the...
- The Defense Logistics Agency awarded a delivery order valued at $6,661.37 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed price, competitively awarded contract—with no set-aside designation—was executed on July 22, 2025, with an ultimate completion date of July 23, 2025. The award reflects a rapid fulfillment timeline typical of delivery orders placed against existing contract vehicles. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,897.41 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) valued at $3,359.77, with an ultimate completion date of September 11, 2025. This competitive award, issued September 10, 2025, utilizes firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract valued at $8,801.10. The order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,487.82 to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAMKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,060.55 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order supports DLA's medical supply chain operations, which provide critical pharmaceutical products to military and veteran healthcare systems. Multaq (dronedarone) is an antiarrhythmic medication used in cardiac care, and this procurement exemplifies the type of specialty pharmaceutical commodity that AmerisourceBergen supplies through its prime vendor agreement with DLA Troop Support Medical. As a major pharmaceutical distributor serving federal healthcare needs, AmerisourceBergen has demonstrated capability to meet government procurement requirements through competitive award processes, fulfilling diverse medical supply needs ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 9/15/25 |